{"id":143809,"date":"2025-01-29T15:49:37","date_gmt":"2025-01-29T10:19:37","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=143809"},"modified":"2025-01-29T15:49:39","modified_gmt":"2025-01-29T10:19:39","slug":"pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/","title":{"rendered":"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2319426263\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>An Indian pharma company that specializes in Contrast media Intermediates that are compounds used in CT scans and MRI, Artificial Sweeteners, and APIs, announced their Q3FY25 results with a 91% YoY increase in revenue and a 208 % increase in net profits.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-951949650\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price Movement<\/strong><\/h2><p>With a market capitalization of \u20b910,969 Cr, the share of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/BLUEJET\" target=\"_blank\" rel=\"noreferrer noopener\">Blue Jet Healthcare<\/a><\/strong> opened at \u20b9573, and after the declaration of results, it hit 10% Upper circuit and a new 52-week high at <strong>\u20b9 <\/strong>630. The past month\u2019s return for the stock is 13% and the 1-year return stands at a staggering 65%.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Q3FY25 Results<\/strong><\/h2><p>The company reported a 91% YoY increase in revenue from <strong>\u20b9<\/strong>16.67 Cr in Q2FY24 to \u20b931.83 Cr in Q3FY25. Their Net profit too saw a significant upside with a 208 % YoY increase from \u20b93.21 Cr to \u20b99.89 Cr for the same period.<\/p><p>On a QoQ basis, the company reported an increase of 53% in revenue from <strong>\u20b9 <\/strong>20.82 Cr in the previous quarter, and their net profits saw an increase of 70% from <strong>\u20b9 <\/strong>5.83 Cr for the same period.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3505924145\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Updates from the Company<\/strong><\/h2><p>The Board has approved investments of up to <strong>\u20b9<\/strong>40 Cr for setting up of Research and Development Facility&nbsp;&nbsp;<\/p><p>During the previous year, an incident at the Mahad facility resulted in a loss of damaged assets and compensation to employees aggregating to <strong>\u20b9<\/strong>9.73 Cr accounted for as exceptional items by the company.<\/p><p>The Company changed its accounting method for depreciation from the Written Down Value (WDV) to the Straight-Line Method (SLM).<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company<\/strong><\/h2><p>Blue Jet Healthcare is a global, science-led, pharmaceutical company that evolved as a Strategic Partner for the Collaboration, Development &amp; Manufacturing of advanced Pharmaceutical Intermediates and API.&nbsp;<\/p><p>Having 53 years of history, its know-how and expertise have grown over many years in the development, scale, and commercialization which has now been expanded to include contract development.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By Abhishek Das<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-3755388998\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3056446118\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>An Indian pharma company that specializes in Contrast media Intermediates that are compounds used in CT scans and MRI, Artificial Sweeteners, and APIs, announced their Q3FY25 results with a 91% YoY increase in revenue and a 208 % increase in net profits. Share Price Movement With a market capitalization of \u20b910,969 Cr, the share of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25321,25322,26632,948,936,3157,2597],"class_list":["post-143809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-blue-jet-healthcare","tag-blue-jet-healthcare-latest-news","tag-blue-jet-results","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits<\/title>\n<meta name=\"description\" content=\"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits\" \/>\n<meta property=\"og:description\" content=\"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-29T10:19:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T10:19:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/\",\"name\":\"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2025-01-29T10:19:37+00:00\",\"dateModified\":\"2025-01-29T10:19:39+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits","description":"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits","og_description":"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-01-29T10:19:37+00:00","article_modified_time":"2025-01-29T10:19:39+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/","name":"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2025-01-29T10:19:37+00:00","dateModified":"2025-01-29T10:19:39+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"An Indian pharma company that specializes in contrast media intermediates that are compounds used in CT scans and MRI, artificial sweeteners,","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-10-upper-circuit-after-announcing-208-yoy-increase-in-net-profits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 10% upper circuit after announcing 208% YoY increase in net profits"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/143809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=143809"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/143809\/revisions"}],"predecessor-version":[{"id":143811,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/143809\/revisions\/143811"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=143809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=143809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=143809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}